nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—Small Ligand GPCRs—CNR2—pancreatic cancer	0.0234	0.0797	CbGpPWpGaD
Travoprost—PTGFR—Small Ligand GPCRs—CNR1—pancreatic cancer	0.0168	0.0572	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—SSTR2—pancreatic cancer	0.00913	0.0311	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CCKBR—pancreatic cancer	0.00882	0.03	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—pancreatic cancer	0.00507	0.0173	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.00505	0.0172	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—CCKBR—pancreatic cancer	0.00496	0.0169	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CNR1—pancreatic cancer	0.0048	0.0163	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—pancreatic cancer	0.00443	0.0151	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.00433	0.0148	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.0043	0.0146	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GAST—pancreatic cancer	0.00426	0.0145	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.00412	0.014	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.00397	0.0135	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—CCK—pancreatic cancer	0.00385	0.0131	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.00383	0.0131	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—pancreatic cancer	0.00381	0.013	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—CCKAR—pancreatic cancer	0.00369	0.0126	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.00368	0.0125	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00353	0.012	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00346	0.0118	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatic cancer	0.00345	0.0117	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.0034	0.0116	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatic cancer	0.0033	0.0113	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—PRLHR—pancreatic cancer	0.0033	0.0112	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.00328	0.0112	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.0029	0.00989	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.00286	0.00973	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SSTR3—pancreatic cancer	0.0028	0.00955	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SSTR1—pancreatic cancer	0.00269	0.00916	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—PPY—pancreatic cancer	0.00264	0.00898	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GCG—pancreatic cancer	0.0026	0.00887	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SSTR2—pancreatic cancer	0.00259	0.00882	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00255	0.0087	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCKBR—pancreatic cancer	0.0025	0.00851	CbGpPWpGaD
Travoprost—Tafluprost—PTGS2—pancreatic cancer	0.0025	1	CrCbGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00249	0.00847	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.00248	0.00846	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00245	0.00834	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00233	0.00793	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.00222	0.00757	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00208	0.0071	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SCT—pancreatic cancer	0.00204	0.00694	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCK—pancreatic cancer	0.00194	0.00662	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00193	0.00659	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00192	0.00654	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GLP1R—pancreatic cancer	0.00189	0.00645	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CNR2—pancreatic cancer	0.00189	0.00645	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCKAR—pancreatic cancer	0.00186	0.00635	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00179	0.00608	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SHH—pancreatic cancer	0.0017	0.00579	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRLHR—pancreatic cancer	0.00169	0.00577	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—IAPP—pancreatic cancer	0.00168	0.00572	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00164	0.0056	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—PTCH1—pancreatic cancer	0.00161	0.00549	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—PTHLH—pancreatic cancer	0.00161	0.00549	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00158	0.0054	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GDI1—pancreatic cancer	0.00155	0.00529	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GDI2—pancreatic cancer	0.00155	0.00529	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00152	0.00518	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PPY—pancreatic cancer	0.00149	0.00508	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SST—pancreatic cancer	0.00147	0.00502	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00146	0.00498	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR3—pancreatic cancer	0.00144	0.0049	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00141	0.00481	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR1—pancreatic cancer	0.00138	0.0047	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CNR1—pancreatic cancer	0.00136	0.00463	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PPY—pancreatic cancer	0.00135	0.00461	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR2—pancreatic cancer	0.00133	0.00452	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GCG—pancreatic cancer	0.00131	0.00447	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCKBR—pancreatic cancer	0.00128	0.00437	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGTR1—pancreatic cancer	0.00125	0.00427	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GAST—pancreatic cancer	0.00121	0.00414	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SCT—pancreatic cancer	0.00115	0.00392	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GAST—pancreatic cancer	0.0011	0.00376	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCK—pancreatic cancer	0.0011	0.00374	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CNR2—pancreatic cancer	0.00107	0.00365	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00107	0.00365	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00105	0.00359	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SCT—pancreatic cancer	0.00105	0.00356	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRLHR—pancreatic cancer	0.001	0.00341	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCK—pancreatic cancer	0.000997	0.0034	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CNR2—pancreatic cancer	0.000972	0.00331	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GLP1R—pancreatic cancer	0.000972	0.00331	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCKAR—pancreatic cancer	0.000956	0.00326	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—IAPP—pancreatic cancer	0.000948	0.00323	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ACVR1B—pancreatic cancer	0.00094	0.0032	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ZNRF3—pancreatic cancer	0.00094	0.0032	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00091	0.0031	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SHH—pancreatic cancer	0.000872	0.00297	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IAPP—pancreatic cancer	0.000861	0.00293	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR3—pancreatic cancer	0.00085	0.0029	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DTX1—pancreatic cancer	0.00085	0.0029	CbGpPWpGaD
Travoprost—Oedema—Fluorouracil—pancreatic cancer	0.000847	0.0012	CcSEcCtD
Travoprost—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000845	0.0012	CcSEcCtD
Travoprost—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000845	0.0012	CcSEcCtD
Travoprost—Urethral disorder—Docetaxel—pancreatic cancer	0.000843	0.0012	CcSEcCtD
Travoprost—Infection—Fluorouracil—pancreatic cancer	0.000841	0.00119	CcSEcCtD
Travoprost—Skin disorder—Gemcitabine—pancreatic cancer	0.000836	0.00119	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—SST—pancreatic cancer	0.000832	0.00284	CbGpPWpGaD
Travoprost—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00083	0.00118	CcSEcCtD
Travoprost—Visual impairment—Docetaxel—pancreatic cancer	0.000829	0.00118	CcSEcCtD
Travoprost—Dizziness—Tamoxifen—pancreatic cancer	0.000829	0.00118	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PTHLH—pancreatic cancer	0.000826	0.00282	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PTCH1—pancreatic cancer	0.000826	0.00282	CbGpPWpGaD
Travoprost—Tachycardia—Fluorouracil—pancreatic cancer	0.000826	0.00117	CcSEcCtD
Travoprost—Hypotension—Irinotecan—pancreatic cancer	0.000826	0.00117	CcSEcCtD
Travoprost—Dizziness—Erlotinib—pancreatic cancer	0.00082	0.00116	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000816	0.00278	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR1—pancreatic cancer	0.000815	0.00278	CbGpPWpGaD
Travoprost—Hypotension—Gemcitabine—pancreatic cancer	0.000805	0.00114	CcSEcCtD
Travoprost—Eye disorder—Docetaxel—pancreatic cancer	0.000804	0.00114	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PPY—pancreatic cancer	0.000799	0.00272	CbGpPWpGaD
Travoprost—Cardiac disorder—Docetaxel—pancreatic cancer	0.000798	0.00113	CcSEcCtD
Travoprost—Hypotension—Fluorouracil—pancreatic cancer	0.000791	0.00112	CcSEcCtD
Travoprost—Hypersensitivity—Sunitinib—pancreatic cancer	0.000791	0.00112	CcSEcCtD
Travoprost—Rash—Tamoxifen—pancreatic cancer	0.00079	0.00112	CcSEcCtD
Travoprost—Dermatitis—Tamoxifen—pancreatic cancer	0.000789	0.00112	CcSEcCtD
Travoprost—Dyspnoea—Irinotecan—pancreatic cancer	0.000788	0.00112	CcSEcCtD
Travoprost—Headache—Tamoxifen—pancreatic cancer	0.000785	0.00112	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000785	0.00111	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SSTR2—pancreatic cancer	0.000785	0.00267	CbGpPWpGaD
Travoprost—Rash—Erlotinib—pancreatic cancer	0.000782	0.00111	CcSEcCtD
Travoprost—Dermatitis—Erlotinib—pancreatic cancer	0.000781	0.00111	CcSEcCtD
Travoprost—Angiopathy—Docetaxel—pancreatic cancer	0.00078	0.00111	CcSEcCtD
Travoprost—Dyspepsia—Irinotecan—pancreatic cancer	0.000778	0.00111	CcSEcCtD
Travoprost—Immune system disorder—Docetaxel—pancreatic cancer	0.000777	0.0011	CcSEcCtD
Travoprost—Headache—Erlotinib—pancreatic cancer	0.000777	0.0011	CcSEcCtD
Travoprost—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000775	0.0011	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000771	0.0011	CcSEcCtD
Travoprost—Asthenia—Sunitinib—pancreatic cancer	0.00077	0.00109	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CNR1—pancreatic cancer	0.000768	0.00262	CbGpPWpGaD
Travoprost—Dyspnoea—Gemcitabine—pancreatic cancer	0.000768	0.00109	CcSEcCtD
Travoprost—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000763	0.00108	CcSEcCtD
Travoprost—Fatigue—Irinotecan—pancreatic cancer	0.000762	0.00108	CcSEcCtD
Travoprost—Pruritus—Sunitinib—pancreatic cancer	0.000759	0.00108	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCKBR—pancreatic cancer	0.000758	0.00258	CbGpPWpGaD
Travoprost—Pain—Irinotecan—pancreatic cancer	0.000756	0.00107	CcSEcCtD
Travoprost—Constipation—Irinotecan—pancreatic cancer	0.000756	0.00107	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—SST—pancreatic cancer	0.000756	0.00258	CbGpPWpGaD
Travoprost—Dyspnoea—Fluorouracil—pancreatic cancer	0.000755	0.00107	CcSEcCtD
Travoprost—Mental disorder—Docetaxel—pancreatic cancer	0.000754	0.00107	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000754	0.00257	CbGpPWpGaD
Travoprost—Erythema—Docetaxel—pancreatic cancer	0.000749	0.00106	CcSEcCtD
Travoprost—Dyspepsia—Fluorouracil—pancreatic cancer	0.000745	0.00106	CcSEcCtD
Travoprost—Nausea—Tamoxifen—pancreatic cancer	0.000744	0.00106	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000744	0.00253	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000743	0.00106	CcSEcCtD
Travoprost—Fatigue—Gemcitabine—pancreatic cancer	0.000742	0.00105	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GCG—pancreatic cancer	0.000742	0.00253	CbGpPWpGaD
Travoprost—Pain—Gemcitabine—pancreatic cancer	0.000736	0.00105	CcSEcCtD
Travoprost—Constipation—Gemcitabine—pancreatic cancer	0.000736	0.00105	CcSEcCtD
Travoprost—Nausea—Erlotinib—pancreatic cancer	0.000736	0.00105	CcSEcCtD
Travoprost—Diarrhoea—Sunitinib—pancreatic cancer	0.000734	0.00104	CcSEcCtD
Travoprost—Dysgeusia—Docetaxel—pancreatic cancer	0.000733	0.00104	CcSEcCtD
Travoprost—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000731	0.00104	CcSEcCtD
Travoprost—Feeling abnormal—Irinotecan—pancreatic cancer	0.000729	0.00103	CcSEcCtD
Travoprost—Influenza—Epirubicin—pancreatic cancer	0.000725	0.00103	CcSEcCtD
Travoprost—Asthma—Epirubicin—pancreatic cancer	0.000725	0.00103	CcSEcCtD
Travoprost—Back pain—Docetaxel—pancreatic cancer	0.000724	0.00103	CcSEcCtD
Travoprost—Pain—Fluorouracil—pancreatic cancer	0.000724	0.00103	CcSEcCtD
Travoprost—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000723	0.00103	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000722	0.00246	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DTX4—pancreatic cancer	0.000712	0.00243	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GLI1—pancreatic cancer	0.000712	0.00243	CbGpPWpGaD
Travoprost—Dizziness—Sunitinib—pancreatic cancer	0.00071	0.00101	CcSEcCtD
Travoprost—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00071	0.00101	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000708	0.00241	CbGpPWpGaD
Travoprost—Angina pectoris—Epirubicin—pancreatic cancer	0.000706	0.001	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000703	0.00239	CbGpPWpGaD
Travoprost—Abdominal pain—Irinotecan—pancreatic cancer	0.000699	0.000993	CcSEcCtD
Travoprost—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000698	0.000991	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CNR1—pancreatic cancer	0.000698	0.00238	CbGpPWpGaD
Travoprost—Bronchitis—Epirubicin—pancreatic cancer	0.000697	0.00099	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NRP1—pancreatic cancer	0.000693	0.00236	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000693	0.00236	CbGpPWpGaD
Travoprost—Dysuria—Epirubicin—pancreatic cancer	0.000678	0.000963	CcSEcCtD
Travoprost—Rash—Sunitinib—pancreatic cancer	0.000677	0.000961	CcSEcCtD
Travoprost—Dermatitis—Sunitinib—pancreatic cancer	0.000676	0.00096	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GCG—pancreatic cancer	0.000674	0.0023	CbGpPWpGaD
Travoprost—Headache—Sunitinib—pancreatic cancer	0.000672	0.000955	CcSEcCtD
Travoprost—Asthma—Doxorubicin—pancreatic cancer	0.000671	0.000953	CcSEcCtD
Travoprost—Influenza—Doxorubicin—pancreatic cancer	0.000671	0.000953	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HEY2—pancreatic cancer	0.000667	0.00227	CbGpPWpGaD
Travoprost—Palpitations—Docetaxel—pancreatic cancer	0.000662	0.00094	CcSEcCtD
Travoprost—Cough—Docetaxel—pancreatic cancer	0.000653	0.000928	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—pancreatic cancer	0.000653	0.000928	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GAST—pancreatic cancer	0.000652	0.00222	CbGpPWpGaD
Travoprost—Hypersensitivity—Irinotecan—pancreatic cancer	0.000651	0.000925	CcSEcCtD
Travoprost—Hypertension—Docetaxel—pancreatic cancer	0.000647	0.000918	CcSEcCtD
Travoprost—Infestation NOS—Epirubicin—pancreatic cancer	0.000646	0.000918	CcSEcCtD
Travoprost—Infestation—Epirubicin—pancreatic cancer	0.000646	0.000918	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000646	0.0022	CbGpPWpGaD
Travoprost—Bronchitis—Doxorubicin—pancreatic cancer	0.000645	0.000916	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000643	0.00219	CbGpPWpGaD
Travoprost—Chest pain—Docetaxel—pancreatic cancer	0.000638	0.000906	CcSEcCtD
Travoprost—Myalgia—Docetaxel—pancreatic cancer	0.000638	0.000906	CcSEcCtD
Travoprost—Arthralgia—Docetaxel—pancreatic cancer	0.000638	0.000906	CcSEcCtD
Travoprost—Nausea—Sunitinib—pancreatic cancer	0.000638	0.000906	CcSEcCtD
Travoprost—Asthenia—Irinotecan—pancreatic cancer	0.000634	0.000901	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000633	0.000899	CcSEcCtD
Travoprost—Conjunctivitis—Epirubicin—pancreatic cancer	0.000628	0.000892	CcSEcCtD
Travoprost—Urinary tract infection—Epirubicin—pancreatic cancer	0.000628	0.000892	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—pancreatic cancer	0.000627	0.000891	CcSEcCtD
Travoprost—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000624	0.000886	CcSEcCtD
Travoprost—Dry mouth—Docetaxel—pancreatic cancer	0.000623	0.000886	CcSEcCtD
Travoprost—Asthenia—Gemcitabine—pancreatic cancer	0.000618	0.000878	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SCT—pancreatic cancer	0.000618	0.0021	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HEY1—pancreatic cancer	0.000618	0.0021	CbGpPWpGaD
Travoprost—Oedema—Docetaxel—pancreatic cancer	0.000611	0.000868	CcSEcCtD
Travoprost—Pruritus—Gemcitabine—pancreatic cancer	0.000609	0.000865	CcSEcCtD
Travoprost—Infection—Docetaxel—pancreatic cancer	0.000607	0.000862	CcSEcCtD
Travoprost—Sinusitis—Epirubicin—pancreatic cancer	0.000606	0.000861	CcSEcCtD
Travoprost—Diarrhoea—Irinotecan—pancreatic cancer	0.000605	0.000859	CcSEcCtD
Travoprost—Nervous system disorder—Docetaxel—pancreatic cancer	0.000599	0.000851	CcSEcCtD
Travoprost—Pruritus—Fluorouracil—pancreatic cancer	0.000599	0.000851	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—pancreatic cancer	0.000598	0.000849	CcSEcCtD
Travoprost—Infestation—Doxorubicin—pancreatic cancer	0.000598	0.000849	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000597	0.00203	CbGpPWpGaD
Travoprost—Tachycardia—Docetaxel—pancreatic cancer	0.000596	0.000847	CcSEcCtD
Travoprost—Skin disorder—Docetaxel—pancreatic cancer	0.000594	0.000843	CcSEcCtD
Travoprost—Bradycardia—Epirubicin—pancreatic cancer	0.000591	0.000839	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCK—pancreatic cancer	0.000589	0.00201	CbGpPWpGaD
Travoprost—Diarrhoea—Gemcitabine—pancreatic cancer	0.000589	0.000837	CcSEcCtD
Travoprost—Dizziness—Irinotecan—pancreatic cancer	0.000585	0.00083	CcSEcCtD
Travoprost—Rhinitis—Epirubicin—pancreatic cancer	0.000582	0.000826	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000581	0.000826	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000581	0.000826	CcSEcCtD
Travoprost—Diarrhoea—Fluorouracil—pancreatic cancer	0.000579	0.000823	CcSEcCtD
Travoprost—Pharyngitis—Epirubicin—pancreatic cancer	0.000576	0.000818	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GLP1R—pancreatic cancer	0.000574	0.00196	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CNR2—pancreatic cancer	0.000574	0.00196	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000574	0.00196	CbGpPWpGaD
Travoprost—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000573	0.000814	CcSEcCtD
Travoprost—Hypotension—Docetaxel—pancreatic cancer	0.000571	0.000811	CcSEcCtD
Travoprost—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00057	0.00081	CcSEcCtD
Travoprost—Urethral disorder—Epirubicin—pancreatic cancer	0.000569	0.000808	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCKAR—pancreatic cancer	0.000565	0.00192	CbGpPWpGaD
Travoprost—Sinusitis—Doxorubicin—pancreatic cancer	0.000561	0.000797	CcSEcCtD
Travoprost—Dizziness—Fluorouracil—pancreatic cancer	0.00056	0.000795	CcSEcCtD
Travoprost—Visual impairment—Epirubicin—pancreatic cancer	0.000559	0.000794	CcSEcCtD
Travoprost—Rash—Irinotecan—pancreatic cancer	0.000557	0.000792	CcSEcCtD
Travoprost—Dermatitis—Irinotecan—pancreatic cancer	0.000557	0.000791	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000557	0.000791	CcSEcCtD
Travoprost—Headache—Irinotecan—pancreatic cancer	0.000554	0.000787	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—JAG2—pancreatic cancer	0.000548	0.00187	CbGpPWpGaD
Travoprost—Bradycardia—Doxorubicin—pancreatic cancer	0.000547	0.000776	CcSEcCtD
Travoprost—Dyspnoea—Docetaxel—pancreatic cancer	0.000545	0.000774	CcSEcCtD
Travoprost—Rash—Gemcitabine—pancreatic cancer	0.000543	0.000771	CcSEcCtD
Travoprost—Dermatitis—Gemcitabine—pancreatic cancer	0.000542	0.000771	CcSEcCtD
Travoprost—Eye disorder—Epirubicin—pancreatic cancer	0.000542	0.00077	CcSEcCtD
Travoprost—Tinnitus—Epirubicin—pancreatic cancer	0.000541	0.000768	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—MEN1—pancreatic cancer	0.00054	0.00184	CbGpPWpGaD
Travoprost—Headache—Gemcitabine—pancreatic cancer	0.000539	0.000766	CcSEcCtD
Travoprost—Cardiac disorder—Epirubicin—pancreatic cancer	0.000538	0.000765	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—pancreatic cancer	0.000538	0.000765	CcSEcCtD
Travoprost—Dyspepsia—Docetaxel—pancreatic cancer	0.000538	0.000764	CcSEcCtD
Travoprost—Rash—Fluorouracil—pancreatic cancer	0.000534	0.000758	CcSEcCtD
Travoprost—Dermatitis—Fluorouracil—pancreatic cancer	0.000533	0.000758	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—pancreatic cancer	0.000533	0.000757	CcSEcCtD
Travoprost—Headache—Fluorouracil—pancreatic cancer	0.00053	0.000754	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00053	0.000753	CcSEcCtD
Travoprost—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000528	0.000749	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000528	0.000749	CcSEcCtD
Travoprost—Fatigue—Docetaxel—pancreatic cancer	0.000527	0.000748	CcSEcCtD
Travoprost—Angiopathy—Epirubicin—pancreatic cancer	0.000526	0.000748	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—pancreatic cancer	0.000526	0.000748	CcSEcCtD
Travoprost—Nausea—Irinotecan—pancreatic cancer	0.000525	0.000746	CcSEcCtD
Travoprost—Immune system disorder—Epirubicin—pancreatic cancer	0.000524	0.000744	CcSEcCtD
Travoprost—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000523	0.000743	CcSEcCtD
Travoprost—Pain—Docetaxel—pancreatic cancer	0.000523	0.000742	CcSEcCtD
Travoprost—Constipation—Docetaxel—pancreatic cancer	0.000523	0.000742	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—pancreatic cancer	0.000517	0.000735	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SHH—pancreatic cancer	0.000515	0.00175	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000512	0.00174	CbGpPWpGaD
Travoprost—Nausea—Gemcitabine—pancreatic cancer	0.000512	0.000727	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—IAPP—pancreatic cancer	0.000509	0.00173	CbGpPWpGaD
Travoprost—Mental disorder—Epirubicin—pancreatic cancer	0.000508	0.000722	CcSEcCtD
Travoprost—Erythema—Epirubicin—pancreatic cancer	0.000505	0.000717	CcSEcCtD
Travoprost—Feeling abnormal—Docetaxel—pancreatic cancer	0.000504	0.000715	CcSEcCtD
Travoprost—Nausea—Fluorouracil—pancreatic cancer	0.000503	0.000714	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—pancreatic cancer	0.000502	0.000713	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—pancreatic cancer	0.000501	0.000711	CcSEcCtD
Travoprost—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0005	0.00071	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000498	0.000708	CcSEcCtD
Travoprost—Dysgeusia—Epirubicin—pancreatic cancer	0.000495	0.000703	CcSEcCtD
Travoprost—Back pain—Epirubicin—pancreatic cancer	0.000489	0.000694	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PTHLH—pancreatic cancer	0.000488	0.00166	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTCH1—pancreatic cancer	0.000488	0.00166	CbGpPWpGaD
Travoprost—Angiopathy—Doxorubicin—pancreatic cancer	0.000487	0.000692	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—pancreatic cancer	0.000485	0.000689	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000484	0.000687	CcSEcCtD
Travoprost—Abdominal pain—Docetaxel—pancreatic cancer	0.000483	0.000686	CcSEcCtD
Travoprost—Vision blurred—Epirubicin—pancreatic cancer	0.000476	0.000676	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—pancreatic cancer	0.00047	0.000668	CcSEcCtD
Travoprost—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000469	0.000666	CcSEcCtD
Travoprost—Erythema—Doxorubicin—pancreatic cancer	0.000467	0.000664	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—pancreatic cancer	0.000458	0.00065	CcSEcCtD
Travoprost—Malaise—Epirubicin—pancreatic cancer	0.000455	0.000647	CcSEcCtD
Travoprost—Vertigo—Epirubicin—pancreatic cancer	0.000454	0.000645	CcSEcCtD
Travoprost—Back pain—Doxorubicin—pancreatic cancer	0.000452	0.000642	CcSEcCtD
Travoprost—Hypersensitivity—Docetaxel—pancreatic cancer	0.00045	0.00064	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SST—pancreatic cancer	0.000447	0.00152	CbGpPWpGaD
Travoprost—Palpitations—Epirubicin—pancreatic cancer	0.000446	0.000634	CcSEcCtD
Travoprost—Cough—Epirubicin—pancreatic cancer	0.000441	0.000626	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—pancreatic cancer	0.00044	0.000626	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00044	0.0015	CbGpPWpGaD
Travoprost—Asthenia—Docetaxel—pancreatic cancer	0.000438	0.000623	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—JAG1—pancreatic cancer	0.000437	0.00149	CbGpPWpGaD
Travoprost—Hypertension—Epirubicin—pancreatic cancer	0.000436	0.000619	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000435	0.00148	CbGpPWpGaD
Travoprost—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000434	0.000616	CcSEcCtD
Travoprost—Pruritus—Docetaxel—pancreatic cancer	0.000432	0.000614	CcSEcCtD
Travoprost—Chest pain—Epirubicin—pancreatic cancer	0.00043	0.000611	CcSEcCtD
Travoprost—Arthralgia—Epirubicin—pancreatic cancer	0.00043	0.000611	CcSEcCtD
Travoprost—Myalgia—Epirubicin—pancreatic cancer	0.00043	0.000611	CcSEcCtD
Travoprost—Anxiety—Epirubicin—pancreatic cancer	0.000429	0.000609	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000427	0.000607	CcSEcCtD
Travoprost—Discomfort—Epirubicin—pancreatic cancer	0.000425	0.000603	CcSEcCtD
Travoprost—Malaise—Doxorubicin—pancreatic cancer	0.000421	0.000599	CcSEcCtD
Travoprost—Dry mouth—Epirubicin—pancreatic cancer	0.000421	0.000597	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—pancreatic cancer	0.00042	0.000596	CcSEcCtD
Travoprost—Diarrhoea—Docetaxel—pancreatic cancer	0.000418	0.000594	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—pancreatic cancer	0.000413	0.000587	CcSEcCtD
Travoprost—Oedema—Epirubicin—pancreatic cancer	0.000412	0.000586	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CNR1—pancreatic cancer	0.000412	0.0014	CbGpPWpGaD
Travoprost—Infection—Epirubicin—pancreatic cancer	0.00041	0.000582	CcSEcCtD
Travoprost—Cough—Doxorubicin—pancreatic cancer	0.000408	0.000579	CcSEcCtD
Travoprost—Nervous system disorder—Epirubicin—pancreatic cancer	0.000404	0.000574	CcSEcCtD
Travoprost—Dizziness—Docetaxel—pancreatic cancer	0.000404	0.000574	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—pancreatic cancer	0.000403	0.000573	CcSEcCtD
Travoprost—Tachycardia—Epirubicin—pancreatic cancer	0.000402	0.000571	CcSEcCtD
Travoprost—Skin disorder—Epirubicin—pancreatic cancer	0.0004	0.000569	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.0004	0.00136	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GCG—pancreatic cancer	0.000398	0.00136	CbGpPWpGaD
Travoprost—Myalgia—Doxorubicin—pancreatic cancer	0.000398	0.000565	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—pancreatic cancer	0.000398	0.000565	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—pancreatic cancer	0.000398	0.000565	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—pancreatic cancer	0.000396	0.000563	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000395	0.000561	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—pancreatic cancer	0.000393	0.000558	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—pancreatic cancer	0.000389	0.000553	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000387	0.00132	CbGpPWpGaD
Travoprost—Rash—Docetaxel—pancreatic cancer	0.000385	0.000547	CcSEcCtD
Travoprost—Hypotension—Epirubicin—pancreatic cancer	0.000385	0.000547	CcSEcCtD
Travoprost—Dermatitis—Docetaxel—pancreatic cancer	0.000385	0.000547	CcSEcCtD
Travoprost—Headache—Docetaxel—pancreatic cancer	0.000383	0.000544	CcSEcCtD
Travoprost—Oedema—Doxorubicin—pancreatic cancer	0.000381	0.000542	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AGTR1—pancreatic cancer	0.00038	0.00129	CbGpPWpGaD
Travoprost—Infection—Doxorubicin—pancreatic cancer	0.000379	0.000538	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000376	0.000533	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—STK11—pancreatic cancer	0.000374	0.00127	CbGpPWpGaD
Travoprost—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000374	0.000531	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—pancreatic cancer	0.000372	0.000529	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—pancreatic cancer	0.00037	0.000526	CcSEcCtD
Travoprost—Dyspnoea—Epirubicin—pancreatic cancer	0.000368	0.000522	CcSEcCtD
Travoprost—Nausea—Docetaxel—pancreatic cancer	0.000363	0.000516	CcSEcCtD
Travoprost—Dyspepsia—Epirubicin—pancreatic cancer	0.000363	0.000515	CcSEcCtD
Travoprost—Hypotension—Doxorubicin—pancreatic cancer	0.000356	0.000506	CcSEcCtD
Travoprost—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000356	0.000506	CcSEcCtD
Travoprost—Fatigue—Epirubicin—pancreatic cancer	0.000355	0.000505	CcSEcCtD
Travoprost—Constipation—Epirubicin—pancreatic cancer	0.000352	0.000501	CcSEcCtD
Travoprost—Pain—Epirubicin—pancreatic cancer	0.000352	0.000501	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000352	0.0012	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000347	0.000494	CcSEcCtD
Travoprost—Dyspnoea—Doxorubicin—pancreatic cancer	0.00034	0.000483	CcSEcCtD
Travoprost—Feeling abnormal—Epirubicin—pancreatic cancer	0.00034	0.000483	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000337	0.00115	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000337	0.000479	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—pancreatic cancer	0.000336	0.000477	CcSEcCtD
Travoprost—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000329	0.000468	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—pancreatic cancer	0.000329	0.000467	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SMAD4—pancreatic cancer	0.000328	0.00112	CbGpPWpGaD
Travoprost—Pain—Doxorubicin—pancreatic cancer	0.000326	0.000463	CcSEcCtD
Travoprost—Constipation—Doxorubicin—pancreatic cancer	0.000326	0.000463	CcSEcCtD
Travoprost—Abdominal pain—Epirubicin—pancreatic cancer	0.000326	0.000463	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000324	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HES1—pancreatic cancer	0.00032	0.00109	CbGpPWpGaD
Travoprost—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000314	0.000446	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000312	0.000443	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000306	0.00104	CbGpPWpGaD
Travoprost—Hypersensitivity—Epirubicin—pancreatic cancer	0.000304	0.000431	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—pancreatic cancer	0.000302	0.000428	CcSEcCtD
Travoprost—Asthenia—Epirubicin—pancreatic cancer	0.000296	0.00042	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CXCL8—pancreatic cancer	0.000294	0.001	CbGpPWpGaD
Travoprost—Pruritus—Epirubicin—pancreatic cancer	0.000292	0.000414	CcSEcCtD
Travoprost—Diarrhoea—Epirubicin—pancreatic cancer	0.000282	0.000401	CcSEcCtD
Travoprost—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000281	0.000399	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—TERT—pancreatic cancer	0.00028	0.000955	CbGpPWpGaD
Travoprost—Asthenia—Doxorubicin—pancreatic cancer	0.000274	0.000389	CcSEcCtD
Travoprost—Dizziness—Epirubicin—pancreatic cancer	0.000273	0.000387	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—pancreatic cancer	0.00027	0.000383	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HIF1A—pancreatic cancer	0.000268	0.000914	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TSC2—pancreatic cancer	0.000268	0.000911	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOE—pancreatic cancer	0.000262	0.000892	CbGpPWpGaD
Travoprost—Diarrhoea—Doxorubicin—pancreatic cancer	0.000261	0.000371	CcSEcCtD
Travoprost—Rash—Epirubicin—pancreatic cancer	0.00026	0.000369	CcSEcCtD
Travoprost—Dermatitis—Epirubicin—pancreatic cancer	0.00026	0.000369	CcSEcCtD
Travoprost—Headache—Epirubicin—pancreatic cancer	0.000258	0.000367	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—KDR—pancreatic cancer	0.000256	0.000874	CbGpPWpGaD
Travoprost—Dizziness—Doxorubicin—pancreatic cancer	0.000252	0.000358	CcSEcCtD
Travoprost—Nausea—Epirubicin—pancreatic cancer	0.000245	0.000348	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NFKBIA—pancreatic cancer	0.000244	0.000831	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000242	0.000823	CbGpPWpGaD
Travoprost—Rash—Doxorubicin—pancreatic cancer	0.00024	0.000342	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—pancreatic cancer	0.00024	0.000341	CcSEcCtD
Travoprost—Headache—Doxorubicin—pancreatic cancer	0.000239	0.000339	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000236	0.000805	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NRAS—pancreatic cancer	0.000236	0.000805	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGF—pancreatic cancer	0.000234	0.000796	CbGpPWpGaD
Travoprost—Nausea—Doxorubicin—pancreatic cancer	0.000227	0.000322	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—EGFR—pancreatic cancer	0.000215	0.000733	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000208	0.000708	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000206	0.000701	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KRAS—pancreatic cancer	0.000203	0.000693	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000187	0.000636	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CB—pancreatic cancer	0.000181	0.000617	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL8—pancreatic cancer	0.000174	0.000593	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HRAS—pancreatic cancer	0.000173	0.000589	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—pancreatic cancer	0.000168	0.000573	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP3—pancreatic cancer	0.000167	0.000567	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCND1—pancreatic cancer	0.000162	0.000552	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CTNNB1—pancreatic cancer	0.000161	0.000547	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—pancreatic cancer	0.000157	0.000536	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTEN—pancreatic cancer	0.000156	0.000533	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—pancreatic cancer	0.000153	0.00052	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SRC—pancreatic cancer	0.000145	0.000494	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—pancreatic cancer	0.000141	0.000481	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT3—pancreatic cancer	0.00014	0.000477	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NRAS—pancreatic cancer	0.00014	0.000475	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—pancreatic cancer	0.00013	0.000443	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—pancreatic cancer	0.00013	0.000442	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGFR—pancreatic cancer	0.000127	0.000433	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KRAS—pancreatic cancer	0.00012	0.000409	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—pancreatic cancer	0.00011	0.000376	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TP53—pancreatic cancer	0.000107	0.000364	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRAS—pancreatic cancer	0.000102	0.000348	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—pancreatic cancer	9.02e-05	0.000307	CbGpPWpGaD
